Rebecca Taub
2018
In 2018, Rebecca Taub earned a total compensation of $4.3M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals, a 298% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,330 |
|---|---|
| Option Awards | $3,729,700 |
| Salary | $385,416 |
| Total | $4,340,446 |
Taub received $3.7M in option awards, accounting for 86% of the total pay in 2018.
Taub also received $225.3K in non-equity incentive plan and $385.4K in salary.
Rankings
In 2018, Rebecca Taub's compensation ranked 2,496th out of 14,244 executives tracked by ExecPay. In other words, Taub earned more than 82.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,496 out of 14,244 | 83rd |
Division Manufacturing | 920 out of 5,765 | 84th |
Major group Chemicals And Allied Products | 315 out of 2,128 | 85th |
Industry group Drugs | 255 out of 1,817 | 86th |
Industry Pharmaceutical Preparations | 198 out of 1,391 | 86th |
Pay ratio
| Rebecca Taub's Pay | $4,340,446 |
|---|---|
| Median Employee's Pay | $804,000 |
| Pay Ratio | 5to 1 |
In 2018, the annual total compensation of Rebecca Taub was $4,340,446.
The annual total compensation of the median employee at Synta Pharmaceuticals was $804,000.
The ratio of Rebecca Taub's pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on May 15, 2019.
Taub's colleagues
We found two more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2018.